Endo Health Solutions (ENDP) issues a statement in response to the FDA's decision to deny its...

|About: Endo International plc (ENDP)|By:, SA News Editor

Endo Health Solutions (ENDP) issues a statement in response to the FDA's decision to deny its citizen petition and approve a generic version of Lidoderm, saying it's disappointed with the outcome. The company says approval of a generic version without requiring clinical endpoint studies is inadequate to establish the safety and efficacy of the medication.